An immunohistochemical study for ESCC identified abnormal CDKN3 protein expression in esophageal squamous-cell cancer (ESCC) patients and confirmed its association with ESCC progression [76]. The gene discussed is CDKN3; the disease is esophageal squamous cell carcinoma.